Cargando…

Using Patient-Reported Outcomes in Dose-Finding Oncology Trials: Surveys of Key Stakeholders and the National Cancer Research Institute Consumer Forum

BACKGROUND: Patient-reported adverse events may be a useful adjunct for assessing a drug’s tolerability in dose-finding oncology trials (DFOT). We conducted surveys of international stakeholders and the National Cancer Research Institute (NCRI) Consumer Forum to understand attitudes about patient-re...

Descripción completa

Detalles Bibliográficos
Autores principales: Lai-Kwon, Julia, Vanderbeek, Alyssa M, Minchom, Anna, Lee Aiyegbusi, Olalekan, Ogunleye, Della, Stephens, Richard, Calvert, Melanie, Yap, Christina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9438918/
https://www.ncbi.nlm.nih.gov/pubmed/35762393
http://dx.doi.org/10.1093/oncolo/oyac117